Atossa Therapeutics ATOS
NASDAQ ATOS
$2.34 +0.07 (+3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Depreciation and Depletion (2012 - 2026)

Updated

Atossa Therapeutics (ATOS) reported Depreciation and Depletion of $4,000 for Q2 2026, unchanged from $4,000 a year earlier and unchanged from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Depreciation and Depletion (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Atossa Therapeutics' Depreciation and Depletion came in at $16,000, unchanged year-over-year; for FY2025, it came in at $16,000, down 5.9% from FY2024.

  • Depreciation and Depletion has a five-year compound annual growth rate of -3.4% (FY2020 to FY2025).
  • By year, Depreciation and Depletion came in at $17,000 in FY2024 (-26.1%), $23,000 in FY2023 (+187.5%), $8,000 in FY2022 (-20.0%) and $10,000 in FY2021 (-47.4%).
  • Five-year quarterly Depreciation and Depletion spans a low of $3,000 in Q1 2023 and a high of $14,000 in Q4 2023.
  • Year over year, Depreciation and Depletion gained in 1 of the last eight quarters, with an average decline of 7.3%.
  • The high point for year-over-year Depreciation and Depletion in five years was Q1 2024 (growth of 66.7%); the low point was Q4 2024 (a decline of 71.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $4,000 (Q1 2026), $4,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Atossa Therapeutics 23.35 Mn 23.35 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 4,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 4,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 14,000.00
Sep 30, 2023 3,000.00
Jun 30, 2023 3,000.00
Mar 31, 2023 3,000.00
Mar 31, 2018 2,725.00
Dec 31, 2017 2,968.00
Sep 30, 2017 4,554.00
Mar 31, 2017 9,662.00
Sep 30, 2016 29,698.00
Jun 30, 2016 32,734.00
API Access

Atossa Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ATOS&period=max&api_key=YOUR_API_KEY